Provision of insourced symptomatic breast one‑stop diagnostic services delivered on Trust premises. The service will support breast cancer pathways through consultant‑led clinics, including diagnostic mammography, ultrasound and biopsy where clinically indicated, together with completion of all associated clinical documentation and reporting, in line with Trust policies and national standards.
Contract period:
The services are intended to commence in June 2026 and will continue until completion of the required activity or exhaustion of available funding. The arrangement may be extended, subject to funding availability and satisfactory performance, with the total duration not exceeding 18 months.